CT imaging characteristics of oncocytic adrenal neoplasms (OANs): comparison with adrenocortical carcinomas
- PMID: 24271078
- DOI: 10.1007/s00261-013-0047-z
CT imaging characteristics of oncocytic adrenal neoplasms (OANs): comparison with adrenocortical carcinomas
Abstract
Objective: Oncocytic adrenal neoplasms (OANs) are rare, but are an important subtype of adrenal tumors that is being diagnosed with increasing frequency. Unfortunately, the imaging characteristics of this tumor have not been well described. Our purpose was to identify CT features to differentiate OANs from adrenocortical carcinomas (ACC).
Materials and methods: From 1991 to 2012, 18 patients with OANs were identified from our institution's pathology database. Twelve had CT examinations available for review. CT characteristics of five benign and seven malignant OANs were reviewed by two abdominal radiologists, and compared to ACC (n = 10). Morphologic characteristics and density measurements were recorded for each imaging phase. Absolute contrast washout was calculated and compared.
Results: Benign OANs were smaller [mean size 3.7 cm (range 2.6-5.3)] and more homogeneous than malignant OANs and demonstrated greater washout [mean washout percentage 72.3% (range 61-88)]. Malignant OANs demonstrated features similar to ACCs, including size [mean 9.4 cm (range 5.2-9.8)] and internal necrosis (n = 6). Mean enhancement washout percentage for malignant OANs was 12% (range -8 to 32).
Conclusion: Benign OANs (oncocytomas) may be distinguished from lipid-rich adenomas on non-contrast CT but may be indistinguishable from lipid-poor adenomas. Malignant oncocytic neoplasms can demonstrate features similar to ACCs, including larger size, internal necrosis, and lower percentage enhancement washout.
Similar articles
-
Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.Radiology. 2005 Feb;234(2):479-85. doi: 10.1148/radiol.2342031876. Radiology. 2005. PMID: 15671003
-
Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry.Eur J Endocrinol. 2015 Apr;172(4):415-22. doi: 10.1530/EJE-14-0916. Epub 2015 Jan 19. Eur J Endocrinol. 2015. PMID: 25599706
-
Oncocytic adrenocortical carcinoma: a rare adrenal tumor subtype.Can J Urol. 2017 Jun;24(3):8865-8867. Can J Urol. 2017. PMID: 28646944
-
[Differential diagnosis of space-occupying adrenal masses].Rofo. 1999 Oct;171(4):269-78. doi: 10.1055/s-1999-252. Rofo. 1999. PMID: 10598161 Review. German.
-
Radiological localizing techniques in adrenal tumors.Minerva Endocrinol. 2009 Jun;34(2):161-9. Minerva Endocrinol. 2009. PMID: 19471240 Review.
Cited by
-
Review of Diagnostic Modalities for Adrenal Incidentaloma.J Clin Med. 2023 May 29;12(11):3739. doi: 10.3390/jcm12113739. J Clin Med. 2023. PMID: 37297933 Free PMC article. Review.
-
Case Report: Adrenocortical Oncocytoma in a Patient with a Previous Contralateral Adrenalectomy for a Cortisol-Secreting Adenoma.Front Surg. 2022 May 19;9:897967. doi: 10.3389/fsurg.2022.897967. eCollection 2022. Front Surg. 2022. PMID: 35662823 Free PMC article.
-
How to Differentiate Benign from Malignant Adrenocortical Tumors?Cancers (Basel). 2021 Aug 30;13(17):4383. doi: 10.3390/cancers13174383. Cancers (Basel). 2021. PMID: 34503194 Free PMC article. Review.
-
ACTH-Independent Cushing's Syndrome Associated with Left Adrenocortical Oncocytoma of Uncertain Malignant Potential.Case Rep Endocrinol. 2020 Sep 26;2020:8816527. doi: 10.1155/2020/8816527. eCollection 2020. Case Rep Endocrinol. 2020. PMID: 33062350 Free PMC article.
-
Adrenal Oncocytoma: An Incidental Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Findings with Magnetic Resonance Imaging Correlation.Indian J Nucl Med. 2018 Oct-Dec;33(4):345-347. doi: 10.4103/ijnm.IJNM_78_18. Indian J Nucl Med. 2018. PMID: 30386060 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
